EcoDrugPlus

Prostaglandin I2 Receptor

Ensembl ID : ENSORLG00000006848
Gene Symbol: PTGIR
4 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSORLG00000000509
Gene Symbol: PTGS1
3 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSORLG00000009468
Gene Symbol: PTGS2B
3 Cross references
214 Possible Orthologues:

Proteasomal Ubiquitin Receptor Adrm1

Ensembl ID : ENSORLG00000014864
Gene Symbol: LOC101171004
3 Cross references
191 Possible Orthologues:

Proteasomal Ubiquitin Receptor Adrm1-Like

Ensembl ID : ENSORLG00000019745
Gene Symbol: LOC101175629
4 Cross references
194 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSORLG00000001217
Gene Symbol: PSMA1
4 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 2a

Ensembl ID : ENSORLG00000006211
Gene Symbol: PSMA2A
4 Cross references
269 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSORLG00000010288
Gene Symbol: PSMA3
4 Cross references
239 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSORLG00000001486
Gene Symbol: PSMA4
4 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSORLG00000015965
Gene Symbol: PSMA5
4 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSORLG00000027101
Gene Symbol: PSMA8
4 Cross references
182 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSORLG00000010803
Gene Symbol: PSMB1
4 Cross references
217 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).